Massive study aims to redefine Lung-Heart disease
NCT ID NCT02980887
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at nearly 1,200 people with or at risk for pulmonary hypertension (high blood pressure in the lungs). Researchers use many advanced tests to find new ways to classify the disease and identify biomarkers. The goal is to better understand the disease and improve future diagnosis and treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21287, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
New York Medical College
Valhalla, New York, 10595, United States
-
University of Arizona Health Sciences Center
Tucson, Arizona, 85721, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Weill Cornell Medicine
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scoliosis's hidden toll: can we predict lung and heart risks?
- Can a new pill ease the strain of pulmonary arterial hypertension?
- Which breathing setting keeps Kids' lungs healthier during heart surgery?
- Could a simple sleep guide ease insomnia in lung disease?
- Could a gut bacteria transplant ease a rare lung disease?
- A Needle-Free heart check? MRI may replace invasive catheterization